View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
U.S. News and World Report ranks Dana-Farber/Brigham and Women's Cancer Center the top hospital in New England for the 14th straight year.
Researchers find that targeting growth-driving cells within tumors, not the fastest-proliferating cells within tumors, may lead to more effective treatments.
In an affirmation of worldwide respect for the impact of Dana-Farber research, 19 basic scientists and clinical investigators at the Institute have been listed among "the world's most influential scientific minds." The ranking was based on how frequently their research discoveries have been cited by peers in the past decade.
In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers from Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities.
Dana-Farber Cancer Institute is recognized as a Magnet® organization for excellence in nursing and patient care for the third time.
Dana-Farber scientists identify a protein that is a cause of cachexia, a severe wasting of fat and muscle in half of all cancer patients, and show that blocking the protein in mice can prevent or halt the debilitating condition.
Dr. Sung-Yun Pai led a study that found children with the immune disorder known as “bubble boy disease” who received stem cell transplants within three-and-a-half months of birth had the highest rates of survival.
Lisa Scherber of the Jimmy Fund Clinic discussed the important memories that former Boston Red Sox pitcher Jon Lester created for patients he has met over the years.
Dr. Kornelia Polyak led a study that suggests that the most dangerous cancer cells are not necessarily those that proliferate the fastest
In a 2013 study conducted by Shoshana Rosenberg, ScD, women younger than 40 with no increased genetic risk and disease in one breast believed that within five years, 10 out of 100 of them would develop it in the other.
Dr. Adam Bass
co-authored a study that developed a molecular classification that divides
gastric cancer into four major genomic subtypes
Dr. Suzanne George commented on a study showing that undetected tumors in women having hysterectomies are more common than many experts had thought, a conclusion that is fueling calls to limit or eliminate a particular hysterectomy procedure.
Becker's Hospital Review named Dana-Farber/Brigham and Women's Cancer Center to the 2014 edition of "100 Hospitals and Health Systems With Great Oncology Programs."
Vote for Your Favorite Red Sox Star for the Chance to Win a Signed Jon Lester Jersey
For over 60 years the Red Sox have had a special bond with the Jimmy Fund and Dana-Farber. Dating from 1953, this is the longest and most successful partnership between a professional sports team and charity in North America. The Red Sox have helped the Jimmy fund raise millions of dollars for cancer care and research at Dana-Farber through appearances and appeals while befriending patients of all ages. In honor of this partnership we are giving away a signed Jon Lester jersey to one lucky fan. Just vote for your favorite Red Sox star here to be entered to win. Contest ends at 11:59pm on Tuesday, August 12.
Patient referral information, clinical resources and more.
For adults:877-442-3324For children:888-733-4662Or complete the online form.
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
More ways to helpGiving Catalog
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: